Cloud-Based Bio Lab Startup Transcriptic Lands $8.5 Million In Series A Funding To Help It Scale



Months after announcing its Y Combinator partnership and moving into a giant new Menlo Park facility, the robot-operated biolab startup Transcriptic has raised $8.5 million in Series A funding.

Data Collective led the round, with participation from IA Ventures, AME Cloud Ventures, Silicon Valley Bank, 500 Startups, MITS Fund, Y Combinator partner Paul Buchheit and several other angel investors.

This brings the total amount of funds to just over $14 million now, giving the cloud-based lab tests startup some room to purchase proprietary equipment and start moving into drug-screening tests.

Currently, Transcriptic is the only cloud-based robotic bio lab in operation. The robotics lab arm of Emerald Therapeutics is a close competitor with a very similar end goal to run science experiments in the cloud. But it is still in the testing phase and not available to the mass public.

Read More

Comments

Popular posts from this blog

NASA’s Super Guppy Gives Mars-Bound Spacecraft A Lift

Dell XPS 13 2015 Review and Giveaway

Who To Follow On Twitter, According To Marc Andreessen